CY1119094T1 - Χρηση παρασκευασματων συνδυασμου που περιλαμβανουν αντιμυκητιακους παραγοντες - Google Patents
Χρηση παρασκευασματων συνδυασμου που περιλαμβανουν αντιμυκητιακους παραγοντεςInfo
- Publication number
- CY1119094T1 CY1119094T1 CY20171100556T CY171100556T CY1119094T1 CY 1119094 T1 CY1119094 T1 CY 1119094T1 CY 20171100556 T CY20171100556 T CY 20171100556T CY 171100556 T CY171100556 T CY 171100556T CY 1119094 T1 CY1119094 T1 CY 1119094T1
- Authority
- CY
- Cyprus
- Prior art keywords
- fishing
- agents
- including anti
- preparations including
- dermatitis
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 1
- 201000004624 Dermatitis Diseases 0.000 abstract 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- 206010050346 Oropharyngeal candidiasis Diseases 0.000 abstract 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 229940000425 combination drug Drugs 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT8262006 | 2006-05-12 | ||
| PCT/AT2007/000227 WO2007131253A2 (de) | 2006-05-12 | 2007-05-10 | Verwendung von kombinationspräparaten, umfassend antimykotika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119094T1 true CY1119094T1 (el) | 2018-01-10 |
Family
ID=37903545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100556T CY1119094T1 (el) | 2006-05-12 | 2017-05-30 | Χρηση παρασκευασματων συνδυασμου που περιλαμβανουν αντιμυκητιακους παραγοντες |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8552042B2 (enExample) |
| EP (2) | EP3192507B1 (enExample) |
| JP (1) | JP2009536926A (enExample) |
| CN (1) | CN101484162A (enExample) |
| AU (1) | AU2007250502B2 (enExample) |
| CA (1) | CA2651726C (enExample) |
| CY (1) | CY1119094T1 (enExample) |
| DK (1) | DK2018164T3 (enExample) |
| ES (1) | ES2627268T3 (enExample) |
| HR (1) | HRP20170793T1 (enExample) |
| HU (1) | HUE033499T2 (enExample) |
| LT (1) | LT2018164T (enExample) |
| NO (2) | NO342103B1 (enExample) |
| PL (1) | PL2018164T3 (enExample) |
| PT (1) | PT2018164T (enExample) |
| RS (1) | RS56044B1 (enExample) |
| RU (1) | RU2008148977A (enExample) |
| SI (1) | SI2018164T1 (enExample) |
| WO (1) | WO2007131253A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI23311A (sl) * | 2010-03-19 | 2011-09-30 | Kemijski inštitut | Farmacevtska kombinacija acetilsalicilne kisline in protiglivne substance za uničevanje ali inhibicijo rasti in replikacije gliv |
| CN102210649A (zh) * | 2010-04-09 | 2011-10-12 | 上海医药科技发展有限公司 | 一种两性霉素b乳膏及其制备方法 |
| FR2993179B1 (fr) * | 2012-07-13 | 2016-01-08 | Lesaffre & Cie | Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales |
| CN103044408A (zh) * | 2013-01-21 | 2013-04-17 | 万礼 | 在治疗恶性肿瘤时应用的伊曲康唑或其盐及其组合物 |
| US8883747B1 (en) * | 2013-10-09 | 2014-11-11 | Craig W. Carver | Topical antifungal compositions and methods of use thereof |
| MX378376B (es) * | 2015-01-13 | 2025-03-10 | Acraf | Composicion farmaceutica para el tratamiento de la micosis. |
| CN104920360B (zh) * | 2015-06-18 | 2017-04-12 | 青岛农业大学 | 丁苯羟酸在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的用途 |
| EP3482743A1 (de) | 2017-11-14 | 2019-05-15 | ProFem GmbH | Emulsionen zur behandlung von scheideninfektionen |
| PL3709969T3 (pl) * | 2017-11-14 | 2024-02-19 | Profem Gmbh | Emulsje do miejscowego leczenia zakażeń skóry i śluzówek |
| EP3482744A1 (de) | 2017-11-14 | 2019-05-15 | ProFem GmbH | Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen |
| FR3089788B1 (fr) * | 2018-12-17 | 2020-12-18 | Lesaffre & Cie | Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées |
| US20250302821A1 (en) * | 2022-05-12 | 2025-10-02 | St. Jude Children's Research Hospital, Inc. | Synergistic antifungal composition and method |
| WO2024187210A1 (de) | 2023-03-15 | 2024-09-19 | Profem Gmbh | Kombinationsarzneimittel zur behandlung und reduktion der rückfallraten vaginaler mykosen |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6471823A (en) * | 1987-09-12 | 1989-03-16 | Rohto Pharma | Sustained remedy for vaginal candidiasis |
| US5087620A (en) * | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
| ES2079994B1 (es) | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
| CA2177683C (en) * | 1993-12-23 | 1999-12-28 | George Endel Deckner | Tissue moisturizing and antimicrobial compositions |
| US6416779B1 (en) * | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| US6159977A (en) | 1998-11-16 | 2000-12-12 | Astan, Inc. | Therapeutic anti-fungal nail preparation |
| WO2000048633A1 (en) | 1999-02-19 | 2000-08-24 | Ligocyte Pharmaceuticals, Inc. | Antibodies against hydrophobic proteins that are protective against candidiasis |
| DK1191939T3 (da) | 1999-03-24 | 2008-02-11 | Zengen Inc | Antimikrobielle aminosyresekvenser afledt fra alfa-melanocytstimulerende hormon |
| GB0108082D0 (en) | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
| US20030181384A1 (en) * | 2001-09-06 | 2003-09-25 | Podolsky Daniel K. | Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
| US20040142910A1 (en) * | 2002-10-21 | 2004-07-22 | Aegis Biosciences Llc | Sulfonated styrene copolymers for medical uses |
| AU2003293529A1 (en) * | 2002-12-16 | 2004-07-29 | Nitromed, Inc. | Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
| US20070099932A1 (en) | 2003-06-25 | 2007-05-03 | Toshihiro Shirouzu | External preparation for athlete's foot treatment |
| ES2237298B1 (es) * | 2003-07-16 | 2006-11-01 | Italfarmaco, S.A. | Formulaciones mucoadhesivas semisolidas. |
| US20050014729A1 (en) * | 2003-07-16 | 2005-01-20 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
| CA2567803A1 (en) * | 2004-05-28 | 2005-12-15 | Schering Corporation | Injectable pharmaceutical suspension comprising posaconazole |
-
2007
- 2007-05-10 PL PL07718439T patent/PL2018164T3/pl unknown
- 2007-05-10 DK DK07718439.8T patent/DK2018164T3/en active
- 2007-05-10 WO PCT/AT2007/000227 patent/WO2007131253A2/de not_active Ceased
- 2007-05-10 AU AU2007250502A patent/AU2007250502B2/en active Active
- 2007-05-10 JP JP2009508042A patent/JP2009536926A/ja active Pending
- 2007-05-10 RS RS20170559A patent/RS56044B1/sr unknown
- 2007-05-10 ES ES07718439.8T patent/ES2627268T3/es active Active
- 2007-05-10 SI SI200731935A patent/SI2018164T1/sl unknown
- 2007-05-10 EP EP17158393.3A patent/EP3192507B1/de active Active
- 2007-05-10 PT PT77184398T patent/PT2018164T/pt unknown
- 2007-05-10 HR HRP20170793TT patent/HRP20170793T1/hr unknown
- 2007-05-10 LT LTEP07718439.8T patent/LT2018164T/lt unknown
- 2007-05-10 CN CNA200780025026XA patent/CN101484162A/zh active Pending
- 2007-05-10 US US12/300,578 patent/US8552042B2/en active Active
- 2007-05-10 HU HUE07718439A patent/HUE033499T2/en unknown
- 2007-05-10 CA CA2651726A patent/CA2651726C/en active Active
- 2007-05-10 EP EP07718439.8A patent/EP2018164B1/de active Active
- 2007-05-10 RU RU2008148977/15A patent/RU2008148977A/ru not_active Application Discontinuation
-
2008
- 2008-12-11 NO NO20085181A patent/NO342103B1/no unknown
-
2013
- 2013-10-02 US US14/044,532 patent/US8815925B2/en active Active
-
2017
- 2017-05-30 CY CY20171100556T patent/CY1119094T1/el unknown
-
2018
- 2018-01-18 NO NO20180083A patent/NO345064B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2018164T3 (en) | 2017-06-12 |
| NO20180083A1 (no) | 2009-02-10 |
| RS56044B1 (sr) | 2017-09-29 |
| WO2007131253A2 (de) | 2007-11-22 |
| US8552042B2 (en) | 2013-10-08 |
| NO20085181L (no) | 2009-02-10 |
| HUE033499T2 (en) | 2017-12-28 |
| AU2007250502B2 (en) | 2013-11-28 |
| JP2009536926A (ja) | 2009-10-22 |
| CA2651726C (en) | 2015-12-15 |
| US20140030312A1 (en) | 2014-01-30 |
| PT2018164T (pt) | 2017-06-12 |
| EP2018164A2 (de) | 2009-01-28 |
| CA2651726A1 (en) | 2007-11-22 |
| PL2018164T3 (pl) | 2017-08-31 |
| EP3192507B1 (de) | 2020-07-08 |
| NO342103B1 (no) | 2018-03-26 |
| SI2018164T1 (sl) | 2017-07-31 |
| RU2008148977A (ru) | 2010-06-20 |
| AU2007250502A1 (en) | 2007-11-22 |
| US20090208558A1 (en) | 2009-08-20 |
| NO345064B1 (no) | 2020-09-14 |
| CN101484162A (zh) | 2009-07-15 |
| EP3192507A1 (de) | 2017-07-19 |
| ES2627268T3 (es) | 2017-07-27 |
| US8815925B2 (en) | 2014-08-26 |
| WO2007131253A3 (de) | 2008-11-27 |
| HRP20170793T1 (hr) | 2017-10-06 |
| LT2018164T (lt) | 2017-07-10 |
| EP2018164B1 (de) | 2017-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119094T1 (el) | Χρηση παρασκευασματων συνδυασμου που περιλαμβανουν αντιμυκητιακους παραγοντες | |
| CL2008001124A1 (es) | Formulacion farmaceutica que comprende al menos un derivado de acido lipoico y un reactivo formador de par ionico, util en el tratamiento del cancer. | |
| CY1122617T1 (el) | Απαλλαγμενες prion συνθεσεις νανοσωματιδιων και μεθοδοι | |
| NO20080068L (no) | Topisk unguale formuleringer | |
| CY1119467T1 (el) | Ζιζανιοκτονες συνθεσεις που περιεχουν λιμονενιο | |
| JP2009536926A5 (enExample) | ||
| EA200802008A1 (ru) | Фармацевтические композиции | |
| ATE449097T1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer | |
| CO6531429A2 (es) | Inhibidores de la tirosina quinasa de bruton | |
| CY1116840T1 (el) | Χρηση 24-norudca | |
| CY1120473T1 (el) | Θεραπεια της ουρικης αρθριτιδας και της υπερουριχαιμιας | |
| EA201170521A1 (ru) | Новые соединения | |
| CY1110153T1 (el) | Μυκητοκτονες συνθεσεις | |
| CL2011003266A1 (es) | Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras. | |
| AU2012283775A8 (en) | Inhibitors of Bruton's tyrosine kinase | |
| CY1111729T1 (el) | Υπογλωσσιο επικαλυμμενο δισκιο | |
| CY1110658T1 (el) | Χρηση του καρραγηνου για τη θεραπεια μολυνσεων απο ρινοϊο | |
| CY1124331T1 (el) | Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης | |
| CL2008001123A1 (es) | Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
| CL2008002242A1 (es) | Compuestos derivados de n-cicloalquil-n-carboxamida, tiocarboxamida, biciclicas o derivados de carboximidamida n-sustituida; composicion fungicida; y metodo para controlar los hongos fitopatogenos de los cultivos. | |
| CY1110098T1 (el) | Βιομηχανικη μεθοδος για τη παρασκευη της γαμμα-λακτονης του 17-υδροξυ-6-βητα,7-βητα, 15-βητα,16-βητα-δις-μεθυλενο-3-οξο-17-αλφα πρεγκν-4-ενο-21-καρβοξυλικου οξεος και ενδιαμεσα κλειδια για την μεθοδο αυτη | |
| EA200702529A1 (ru) | Фунгицидная комбинация биологически активных веществ | |
| CY1112607T1 (el) | Εντομοκτονοι συνδυασμοι που περιλαμβανουν αβαμεκτινη και κυφλουμετοφενη | |
| CY1113424T1 (el) | Μεθοδος αντιμετωπισης του καρκινου ή/και παθησεις με κυτταρικη υπερπλασια και παραγοντες που στοχευουν τον αναβολισμο υαλουρονανης για τον ιδιο σκοπο | |
| ECSP088476A (es) | Combinación de productos activos fungicidas |